Trade wars and bond market disruptions loom over an otherwise buoyant stock market. Technical weakness is also a concern, ...

Group's fourth-quarter 2024 earnings report revealed a stark contrast between earnings per share (EPS) and revenue performance. The company, with a market capitalization of $768.53 million, reported ...

Researchers from The Institute of Cancer Research, London, and Barts Cancer Institute have discovered how the extracellular matrix (ECM) surround ...

Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...

Q4 2024 Earnings Conference Call February 14, 2025 2:30 AM ETCompany ParticipantsMartine Hagen – Head-Investor ...